Showing results (111-120 of 186) with videos related to
Sort By:
Pageof 19
Journal of Thrombosis and Haemostasis : JTH|November 21, 2020
Factor VIII pharmacokinetics associates with genetic modifiers of VWF and FVIII clearance in an adult hemophilia A populationKenichi Ogiwara, Laura L Swystun, A Simonne Paine, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|October 23, 2020
The challenge of genetically unresolved haemophilia A patients: Interest of the combination of whole F8 gene sequencing and functional assaysFanny Lassalle, Yohann Jourdy, Loubna Jouan, et al.Stem Cells (Dayton, Ohio)|July 7, 2007
Ex vivo gene therapy for hemophilia A that enhances safe delivery and sustained in vivo factor VIII expression from lentivirally engineered endothelial progenitorsHideto Matsui, Masaru Shibata, Brian Brown, et al.Nucleic Acids Research|June 22, 2026
Leukemia risk factor ARID5B coordinates HDAC-mediated transcriptional repressionAna P Kutschat, Fabian Frommelt, Brianda L Santini, et al.Thrombosis and Haemostasis|June 12, 2015
Diagnostic accuracy study of a factor VIII ELISA for detection of factor VIII antibodies in congenital and acquired haemophilia APaul Batty, Gary W Moore, Sean Platton, et al.Blood|July 1, 2004
A novel type 2A von Willebrand factor mutation located at the last nucleotide of exon 26 (3538G>A) causes skipping of 2 nonadjacent exonsPaula D James, Lee A O'Brien, Carol A Hegadorn, et al.Blood Advances|January 12, 2022
Novel cysteine substitution p.(Cys1084Tyr) causes variable expressivity of qualitative and quantitative VWF defectsOrla Rawley, Laura L Swystun, Christine Brown, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|February 3, 2011
A microRNA-regulated and GP64-pseudotyped lentiviral vector mediates stable expression of FVIII in a murine model of Hemophilia AHideto Matsui, Carol Hegadorn, Margareth Ozelo, et al.Blood|May 22, 2009
A murine model for induction of long-term immunologic tolerance to factor VIII does not require persistent detectable levels of plasma factor VIII and involves contributions from Foxp3+ T regulatory cellsHideto Matsui, Masaru Shibata, Brian Brown, et al.Journal of Thrombosis and Haemostasis : JTH|July 3, 2022
Longitudinal bleeding assessment in von Willebrand disease utilizing an interim bleeding scoreMichelle Lavin, Pamela Christopherson, Julie Grabell, et al.Pageof 19